299 related articles for article (PubMed ID: 34047880)
1. Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis.
Arundhathi JRD; Mathur SR; Gogia A; Deo SVS; Mohapatra P; Prasad CP
Mol Biol Rep; 2021 May; 48(5):4733-4745. PubMed ID: 34047880
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-kB Activity in Triple-Negative Breast Cancer Cells.
Ma C; Zu X; Liu K; Bode AM; Dong Z; Liu Z; Kim DJ
Mol Cells; 2019 Sep; 42(9):628-636. PubMed ID: 31564074
[TBL] [Abstract][Full Text] [Related]
3. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
Fukushi A; Kim HD; Chang YC; Kim CH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
[TBL] [Abstract][Full Text] [Related]
4. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
[TBL] [Abstract][Full Text] [Related]
5. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
[TBL] [Abstract][Full Text] [Related]
6. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
[TBL] [Abstract][Full Text] [Related]
7. Phosphofructokinase: a mediator of glycolytic flux in cancer progression.
Al Hasawi N; Alkandari MF; Luqmani YA
Crit Rev Oncol Hematol; 2014 Dec; 92(3):312-21. PubMed ID: 24910089
[TBL] [Abstract][Full Text] [Related]
8. Human steroid sulfatase enhances aerobic glycolysis through induction of HIF1α and glycolytic enzymes.
Shin S; Kwon YJ; Ye DJ; Baek HS; Kwon TU; Kim D; Chun YJ
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2464-2474. PubMed ID: 31195119
[TBL] [Abstract][Full Text] [Related]
9. The determinants of metabolic discrepancies in aerobic glycolysis: Providing potential targets for breast cancer treatment.
Littleflower AB; Parambil ST; Antony GR; Subhadradevi L
Biochimie; 2024 May; 220():107-121. PubMed ID: 38184121
[TBL] [Abstract][Full Text] [Related]
10. Control analysis as a tool to understand the formation of the las operon in Lactococcus lactis.
Koebmann B; Solem C; Jensen PR
FEBS J; 2005 May; 272(9):2292-303. PubMed ID: 15853813
[TBL] [Abstract][Full Text] [Related]
11. Intracellular glucose and binding of hexokinase and phosphofructokinase to particulate fractions increase under hypoxia in heart of the amazonian armored catfish (Liposarcus pardalis).
Treberg JR; MacCormack TJ; Lewis JM; Almeida-Val VM; Val AL; Driedzic WR
Physiol Biochem Zool; 2007; 80(5):542-50. PubMed ID: 17717817
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
[TBL] [Abstract][Full Text] [Related]
13. The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition.
Brandi J; Cecconi D; Cordani M; Torrens-Mas M; Pacchiana R; Dalla Pozza E; Butera G; Manfredi M; Marengo E; Oliver J; Roca P; Dando I; Donadelli M
Free Radic Biol Med; 2016 Dec; 101():305-316. PubMed ID: 27989750
[TBL] [Abstract][Full Text] [Related]
14. Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes.
Apostolidi M; Vathiotis IA; Muthusamy V; Gaule P; Gassaway BM; Rimm DL; Rinehart J
Cancer Res; 2021 Aug; 81(16):4346-4359. PubMed ID: 34185676
[TBL] [Abstract][Full Text] [Related]
15. Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.
Zhang LF; Lou JT; Lu MH; Gao C; Zhao S; Li B; Liang S; Li Y; Li D; Liu MF
EMBO J; 2015 Nov; 34(21):2671-85. PubMed ID: 26346275
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
[TBL] [Abstract][Full Text] [Related]
17. Silencing of Pyruvate Kinase M2
Huang S; Zhu W; Zhang F; Chen G; Kou X; Yang X; Ouyang G; Shen J
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56972-56987. PubMed ID: 34797638
[TBL] [Abstract][Full Text] [Related]
18. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
[TBL] [Abstract][Full Text] [Related]
19. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
[TBL] [Abstract][Full Text] [Related]
20. External use of Ruyanneixiao cream efficiently blocks precancerous mammary lesions by interfering with glycolysis induced by inhibition of hypoxia inducible factor-1α, hexokinase 2, phosphofructokinase, and pyruvate kinase M2 expression.
Li X; Ma M; Zhang G; Ma Y; Liao R; Chen R; Yan X; Bie F; Huang M; Liang S
J Tradit Chin Med; 2017 Apr; 37(2):236-43. PubMed ID: 29960297
[No Abstract] [Full Text] [Related]
[Next] [New Search]